AR115881A1 - IMMUNOTHERAPY WITH PEPTIDES RESTRICTED TO B * 07 AND A COMBINATION OF PEPTIDES AGAINST CANCER AND RELATED METHODS - Google Patents
IMMUNOTHERAPY WITH PEPTIDES RESTRICTED TO B * 07 AND A COMBINATION OF PEPTIDES AGAINST CANCER AND RELATED METHODSInfo
- Publication number
- AR115881A1 AR115881A1 ARP190102171A ARP190102171A AR115881A1 AR 115881 A1 AR115881 A1 AR 115881A1 AR P190102171 A ARP190102171 A AR P190102171A AR P190102171 A ARP190102171 A AR P190102171A AR 115881 A1 AR115881 A1 AR 115881A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- refers
- combination
- against cancer
- immunotherapy
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000009169 immunotherapy Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a péptidos, proteínas, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, la presente se refiere a la inmunoterapia contra el cáncer. La presente se refiere asimismo a epítopos peptídicos para linfocitos T asociados a tumores, solos o en combinación con otros péptidos asociados a tumores que, por ejemplo, pueden servir como principios activos farmacéuticos en composiciones vacunales destinadas a estimular respuestas inmunitarias antimorales, o a estimular ex vivo linfocitos T que después serán transferidos a los pacientes. Los péptidos unidos a moléculas del complejo mayor de histocompatibilidad (MHC), o los péptidos como tales, también pueden ser dianas de anticuerpos, de receptores de linfocitos T solubles, y de otras moléculas de unión.This refers to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, this refers to immunotherapy against cancer. The present also refers to peptide epitopes for tumor-associated T lymphocytes, alone or in combination with other tumor-associated peptides that, for example, can serve as active pharmaceutical ingredients in vaccine compositions intended to stimulate antimoral immune responses, or to stimulate ex vivo. T lymphocytes that will later be transferred to patients. Peptides bound to major histocompatibility complex (MHC) molecules, or peptides as such, can also be targets of antibodies, soluble T cell receptors, and other binding molecules.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102018118550 | 2018-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR115881A1 true AR115881A1 (en) | 2021-03-10 |
Family
ID=75905104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102171A AR115881A1 (en) | 2018-07-31 | 2019-07-31 | IMMUNOTHERAPY WITH PEPTIDES RESTRICTED TO B * 07 AND A COMBINATION OF PEPTIDES AGAINST CANCER AND RELATED METHODS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR115881A1 (en) |
-
2019
- 2019-07-31 AR ARP190102171A patent/AR115881A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023001346A1 (en) | Use of peptides in immunotherapy against small cell lung cancer and others. | |
| CL2021002459A1 (en) | Peptides and peptide combinations for use in cancer immunotherapy (divisional of application no. 201902093) | |
| CL2021000842A1 (en) | Peptides and peptide combinations of non-canonical origin for use in immunotherapy against different types of cancer. (divisional application no. 202002123) | |
| CO2018008763A2 (en) | Peptides, combinations of peptides and cells for use in immunotherapy against urinary bladder cancer and other types of cancer | |
| CO2021000534A2 (en) | Immunotherapy with b * 07-restricted peptides and a combination of anticancer peptides and related methods | |
| CR20200560A (en) | PEPTIDES AND PEPTID COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST NON-HADGKINIAN LYMPHOMA (NHL) AND OTHER TYPES OF CANCER (Divisional 2018-0346) | |
| CR20210038A (en) | UTERAL CANCER TREATMENT (Divisional 2018-0460) | |
| CO2019012077A2 (en) | Peptides and combinations thereof for use in immunotherapy against various types of cancer | |
| CO2021004270A2 (en) | B * 44 Restricted Peptides for Use in Cancer Immunotherapy and Related Methods | |
| CO2021003404A2 (en) | Immunotherapy with a * 01-restricted peptides and a combination of anticancer peptides and related methods | |
| CL2022003381A1 (en) | a*03-restricted peptides, use in cancer immunotherapy and related methods (split application 202003371) | |
| CO2020013652A2 (en) | Peptides for use in cancer immunotherapy | |
| CL2021000177A1 (en) | Peptides, peptide combinations, cells and kits for use in cancer immunotherapy (divisional application no. 201802360) | |
| CL2021001336A1 (en) | Immunotherapy with b * 08 restricted peptides and a combination of anticancer peptides and related methods | |
| AR115881A1 (en) | IMMUNOTHERAPY WITH PEPTIDES RESTRICTED TO B * 07 AND A COMBINATION OF PEPTIDES AGAINST CANCER AND RELATED METHODS | |
| AR117437A1 (en) | IMMUNOTHERAPY WITH PEPTIDES RESTRICTED TO B * 08 AND A COMBINATION OF PEPTIDES AGAINST CANCER AND RELATED METHODS | |
| AR114736A1 (en) | PEPTIDES RESTRICTED BY B * 44 FOR USE IN IMMUNOTHERAPY AGAINST CANCER AND RELATED METHODS | |
| AR114532A1 (en) | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER | |
| AR115254A1 (en) | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |